Commercio OVID

Ovid Therapeutics Inc

-

00:00:00

Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment of seizures associated with tuberous sclerosis complex and infantile spasms; and OV350, a small molecule for treating epilepsies. It also develops OV882, a short hairpin RNA gene therapy for the treatment of angelman syndrome; and OV815 for the treatment of kinesin-family of proteins associated neurological disorder. The company has license and collaboration agreements with Healx, AstraZeneca AB, H. Lundbeck A/S, and Northwestern University, as well as Marinus Pharmaceuticals, Inc. The company was incorporated in 2014 and is headquartered in New York, New York.
Leggi tutto...

OVID
Specifiche commerciali

Cifre

3

Punto

0.001

Diffusione

floating

Dimensioni del contratto

1

Volume Min

1

Volume massimo

10,000

Volume Step

1

Scambio lungo (punti)

-0.460

Scambio breve (punti)

-0.270
Disponibile su
MT5, TV, cTrader
Ultimo aggiornamento a Giugno 17, 20:08 GMT+3
*Fonte dei dati: Prezzi del conto MT5 Server Prime

OVID
Calendario economico

Non sono stati trovati dati

Cambiamento 1D

206.604%

Perché BlackBull Mercati?

26k+

Attività negoziabili

1:500

Leva fino a

Regolamentato

Multiregolamentato

24/7

Assistenza clienti

$0

Nessun deposito minimo

Calcolatore del margine

Calculation Results

Current Price

0.76

Required Margin

Converted Currency

Required Margin

Account Base Currency

Calcolatore di profitti e perdite

Calculation Results

PIP Value:

Stop loss in PIPs

Stop loss at :

Take profit in PIPs

Take profit at :

Calcolatore di swap

Calculation Results

0.76

Opportunità di trading

Non sono stati trovati dati
Join Now